Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Suicide Poses a Complicated Risk in Those with Infectious Diseases
Suicide is a major problem for many patients with infectious diseases but pinpointing the exact cause has proven difficult.
Another Adverse Effect of the Opioid Epidemic: Hepatitis C Infections
An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3. 
New Testing & Disease Management Guidelines for Hepatitis C Virus Infections in Unique Populations
The new guidelines include updates on HCV management and testing in pregnant women, individuals who inject drugs, men who have sex with men, and individuals who are incarcerated.
Endocarditis Joins HIV and Hepatitis Among Infections Related to Opioid Epidemic: Public Health Watch
Infections associated with the ongoing opioid epidemic in the United States apparently know no bounds.
Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug Users
Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
Hospital Patients in Colorado at Risk of Hepatitis & HIV Following Surgery
The risk comes after it was found that surgical instruments used for orthopedic and spine surgeries were not cleaned properly and consequently, the sterilization of those instruments was compromised.
Fake Hepatitis B Vaccines Found on the Market in Uganda
Falsified hepatitis B vaccines were discovered at 8 health facilities in Uganda.
Direct-Acting Antiviral Combo Yields High Rates of SVR in Patients with Previous Virologic Failure
The combination of direct-acting antiviral agents glecaprevir/pibrentasvir (G/P), sofosbuvir, and ribavirin yielded a high rate of sustained viral response at weeks 4 and 12 in patients who had previously experienced virologic failure on G/P treatment.
Big advances in treatment can